Arch Venture Fund VII LP Insider Trading $SYRS Syros Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Arch Venture Fund VII LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Arch Venture Fund VII LP. Arch Venture Fund VII LP is 10% Owner in AGIOS PHARMACEUTICALS INC ($AGIO) and 10% Owner in Receptos, Inc. ($RCPT) and 10% Owner in 908 Devices Inc. ($MASS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Juno Therapeutics, Inc. ($JUNO) and 10% Owner in Sage Therapeutics, Inc. ($SAGE).
Arch Venture Fund VII LP in Syros Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Arch Venture Fund VII LP: 10% Owner
Holdings: 4,302,051 shares
Current Value: $46,978,397
Latest Transaction: Jul 17 2019
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Arch Venture Fund VII LP in Syros Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, MASS, AGIO, JUNO, RCPT, SAGE, SYRS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 7.70 | 34,521 | 265,687 | 4,242,051 | 4.3 M to 4.2 M (-0.81 %) |
| Jul 17 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 7.81 | 25,779 | 201,277 | 4,276,572 | 4.3 M to 4.3 M (-0.60 %) |
| Jul 17 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 8.27 | 2,700 | 22,316 | 4,302,051 | 4.3 M to 4.3 M (-0.06 %) |
| Mar 14 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 8.15 | 43,000 | 350,441 | 4,305,051 | 4.3 M to 4.3 M (-0.99 %) |
| Mar 14 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 8.20 | 2,820 | 23,122 | 4,348,051 | 4.4 M to 4.3 M (-0.06 %) |
| Mar 14 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 7.89 | 81,591 | 643,443 | 4,350,871 | 4.4 M to 4.4 M (-1.84 %) |
| Mar 14 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 7.37 | 40,092 | 295,374 | 4,432,462 | 4.5 M to 4.4 M (-0.90 %) |
| Mar 11 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 6.49 | 44,878 | 291,366 | 4,472,554 | 4.5 M to 4.5 M (-0.99 %) |
| Mar 11 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 6.93 | 84,496 | 585,270 | 4,517,432 | 4.6 M to 4.5 M (-1.84 %) |
| Mar 11 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 6.87 | 35,209 | 242,013 | 4,601,928 | 4.6 M to 4.6 M (-0.76 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 1,589,269 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 7,500,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 5,000,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Buy | P | 12.50 | 400,000 | 5,000,000 | 4,637,137 | 4.2 M to 4.6 M (+9.44 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 423,805 | 0 | 4,237,137 | 3.8 M to 4.2 M (+11.11 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 2,000,000 | 0 | 3,813,332 | 1.8 M to 3.8 M (+110.29 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 1,333,333 | 0 | 1,813,332 | 480 K to 1.8 M (+277.78 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 266,666 | 0 | 479,999 | 213.3 K to 480 K (+125.00 %) |
Page: 1